
Steffen Helmling, Ph.D.
Chief Business Officer
Steffen combines scientific insight with commercial leadership to build partnerships across the biopharma industry. With a Ph.D. in Biochemistry from Tufts University School of Medicine, he brings experience in drug discovery R&D and the commercialization of discovery platforms spanning small molecules, mRNA, aptamers and peptide mimetics. His career spans more than 25 years, including over 15 years in executive leadership, where he has led cross-functional business development, alliance management and drug discovery sales teams. He has negotiated R&D collaborations, licensing agreements, strategic partnerships and new company formations with global biopharma companies, emerging biotechs, disease foundations and venture capital firms.

